Hypothalamic Hamartoma Related to Central Precocious Puberty: A Case Report

Hypothalamic hamartoma is a rare congenital lesion that can cause central precocious puberty, gelastic seizures, and neurobehavioral disturbances. This case report aims to describe the clinical presentation, diagnostic evaluation, multidisciplinary management, and follow-up of a boy with hypothalamic hamartoma associated with central precocious puberty. A descriptive case report was developed based on the patient's clinical history, physical examination findings, hormonal assessments, skeletal maturation evaluation, neuroimaging, electroencephalography (EEG), and treatment records. A 4-year-old boy presented with premature sexual development, accelerated linear growth, obesity, developmental delay, aggressive behavior, and brief episodes of involuntary smiling or laughter accompanied by impaired responsiveness. Physical examination revealed bilateral testicular enlargement, with a testicular volume of 12 mL, while serum testosterone levels reached 362 ng/dL and bone age was advanced to 14 years. Magnetic resonance imaging (MRI) revealed a hypothalamic lesion extending into the suprasellar cistern and third ventricle. Surgical resection was associated with a reduction in seizure frequency; however, residual lesion tissue and persistent seizures were observed. Following six months of gonadotropin-releasing hormone (GnRH) agonist therapy, serum testosterone levels decreased to below 2.5 ng/dL, indicating substantial biochemical suppression of pubertal activity. Continued antiseizure medication and behavioral interventions were required. These findings demonstrate that endocrine suppression and neurological improvement may follow distinct clinical trajectories. Early recognition and coordinated multidisciplinary care involving endocrinology, neurology, and developmental specialists are essential for comprehensive management. Continued follow-up is necessary to evaluate seizure control, pubertal suppression, linear growth, and behavioral outcomes. However, the long-term effects of treatment on final adult height cannot be determined from this single case.

Authors

Publication Details

Journal
Jurnal Sehat Indonesia (JUSINDO)
Published
2026-11-17
DOI
https://doi.org/10.59141/-.v8i2.575
Primary Topic
Hypothalamic control of reproductive hormones
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Hypothalamic Hamartoma Related to Central Precocious Puberty: A Case Report

I Made Darma Yuda, I Ketut Krisna Indrawan, I Made Arimbawa
2 links
Jurnal Sehat Indonesia (JUSINDO)
Hypothalamic control of reproductive hormones
article

Hypothalamic Hamartoma Related to Central Precocious Puberty: A Case Report

I Made Darma Yuda, I Ketut Krisna Indrawan, I Made Arimbawa
article en

Abstract

Hypothalamic hamartoma is a rare congenital lesion that can cause central precocious puberty, gelastic seizures, and neurobehavioral disturbances. This case report aims to describe the clinical presentation, diagnostic evaluation, multidisciplinary management, and follow-up of a boy with hypothalamic hamartoma associated with central precocious puberty. A descriptive case report was developed based on the patient's clinical history, physical examination findings, hormonal assessments, skeletal maturation evaluation, neuroimaging, electroencephalography (EEG), and treatment records. A 4-year-old boy presented with premature sexual development, accelerated linear growth, obesity, developmental delay, aggressive behavior, and brief episodes of involuntary smiling or laughter accompanied by impaired responsiveness. Physical examination revealed bilateral testicular enlargement, with a testicular volume of 12 mL, while serum testosterone levels reached 362 ng/dL and bone age was advanced to 14 years. Magnetic resonance imaging (MRI) revealed a hypothalamic lesion extending into the suprasellar cistern and third ventricle. Surgical resection was associated with a reduction in seizure frequency; however, residual lesion tissue and persistent seizures were observed. Following six months of gonadotropin-releasing hormone (GnRH) agonist therapy, serum testosterone levels decreased to below 2.5 ng/dL, indicating substantial biochemical suppression of pubertal activity. Continued antiseizure medication and behavioral interventions were required. These findings demonstrate that endocrine suppression and neurological improvement may follow distinct clinical trajectories. Early recognition and coordinated multidisciplinary care involving endocrinology, neurology, and developmental specialists are essential for comprehensive management. Continued follow-up is necessary to evaluate seizure control, pubertal suppression, linear growth, and behavioral outcomes. However, the long-term effects of treatment on final adult height cannot be determined from this single case.

Jurnal Sehat Indonesia (JUSINDO)Vol. 8(2)
Good health and well-being
Hypothalamic control of reproductive hormones
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon